David Speakman
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 25
- Cutaneous Melanoma Detection and Management 17
- CAR-T cell therapy research 4
- Global Cancer Incidence and Screening 3
- Vascular Tumors and Angiosarcomas 2
-
- Melanoma and MAPK Pathways 13
- Co-authors
- Michael A. Henderson (21 shared papers)David Gyorki (16 shared papers)John Spillane (12 shared papers)Anita Skandarajah (1 shared paper)Carl Yoshizawa (1 shared paper)Calvin Chao (1 shared paper)Richard H. De Boer (1 shared paper)G. Bruce Mann (3 shared papers)
- Journals
- Annals of Surgical Oncology (6 papers)ANZ Journal of Surgery (5 papers)Journal of Surgical Oncology (3 papers)Cancer Research (3 papers)Melanoma Research (2 papers)
- Partner nations
- AustraliaUnited StatesEgypt
In The Last Decade
David Speakman
26 papers receiving 418 citations
Peers
Comparison fields: 5 of 55
- Oncology 310
- Cancer Research 78
- Dermatology 36
- Pulmonary and Respiratory Medicine 92
- Immunology 52
Countries citing papers authored by David Speakman
This map shows the geographic impact of David Speakman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Speakman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Speakman more than expected).
Fields of papers citing papers by David Speakman
This network shows the impact of papers produced by David Speakman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Speakman. The network helps show where David Speakman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Speakman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 56 | |
| 2 | 2012 | 43 | |
| 3 | Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. | 2001 | 40 |
| 4 | 2016 | 24 | |
| 5 | 2015 | 23 | |
| 6 | 2002 | 23 | |
| 7 | 2016 | 23 | |
| 8 | 2016 | 22 | |
| 9 | 2015 | 20 | |
| 10 | 2015 | 19 | |
| 11 | 2014 | 18 | |
| 12 | 2014 | 16 | |
| 13 | 2018 | 15 | |
| 14 | 2011 | 14 | |
| 15 | 2014 | 12 | |
| 16 | 2011 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2016 | 9 | |
| 19 | 2017 | 7 | |
| 20 | 2019 | 6 |
About David Speakman
David Speakman is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 30 papers that have together received 423 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (17 papers), Melanoma and MAPK Pathways (13 papers), CAR-T cell therapy research (4 papers), Nonmelanoma Skin Cancer Studies (3 papers), Global Cancer Incidence and Screening (3 papers), Breast Cancer Treatment Studies (2 papers), Vascular Tumors and Angiosarcomas (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (310 citations), Cancer Research (78 citations), Dermatology (36 citations), Pulmonary and Respiratory Medicine (92 citations) and Immunology (52 citations). David Speakman has collaborated with scholars based in Australia, United States and Egypt. Frequent co-authors include Michael A. Henderson, David Gyorki, John Spillane, Anita Skandarajah, Carl Yoshizawa, Calvin Chao, Richard H. De Boer, G. Bruce Mann, Jill Ainslie and Mark Shackleton. Their work appears in journals such as Annals of Surgical Oncology, ANZ Journal of Surgery, Journal of Surgical Oncology, Cancer Research and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.